PCOS study reveals hidden emotional toll on women
NCT ID NCT05982236
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 100 women with Polycystic Ovary Syndrome (PCOS) to understand how the condition impacts their quality of life and mental health. Researchers examined factors like age, weight, how long it took to get a diagnosis, and history of anxiety or depression. Participants filled out online questionnaires about their well-being. The goal was to find which factors are most linked to poorer quality of life, helping doctors better support patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
100 people
The number who actually took part.
- Started
-
Jul 2023
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patient with PCOS
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female sex * Adult patient (aged 18 or over) * Able to read and write in French * diagnosed at a previous consultation as having PCOS according to the Rotterdam criteria (at least 2 out of 3 criteria from: * Clinical signs of hyperandrogenism (hirsutism, acne, androgenic alopecia) and/or biochemical signs of hyperandrogenism (total testosterone \> 0.39 ng/mL and/or androstenedione \> 1.75 ng/mL) * Ovulation disorders (infertility, oligomenorrhoea or amenorrhoea or cycle length either \<21 days or \>35 days), * Polymicrocystic ovaries on ultrasound (either 19 or more follicles measuring 2-9 mm in diameter and/or increased ovarian volume (\>10 cm3) and/or increased ovarian area (\> 5.5 cm²) without presence of cyst or dominant follicle.) * Informed consent Exclusion Criteria: * Patient with no health insurance cover * Difficulties understanding or speaking French * Computer (tablet/smartphone) and internet connection required. * Refusal to take part in research * Under court protection (guardianship/curatorship/privation of liberty)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Polycystic ovary syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Lille Hôpital Jeanne de Flandre
Lille, Nord, 59000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Antioxidant supplement tested as fertility booster for PCOS
- Fat tissue talks to the ovaries: scientists probe the hidden link
- Acne may signal hidden hormonal disorder in young women
- Can tailored acupuncture help untangle PCOS?
- Can acupuncture help PCOS-Related insulin resistance?
- Can a daily zinc pill tame insulin resistance in polyendocrine ovarian syndrome?